Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dientamoeba fragilis: a bowel pathogen?

R B Oxner, G P Paltridge, B A Chapman

    The New Zealand Medical Journal
    |February 11, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.

    International journal of clinical practice·2013
    Same author

    Two cases of severe liver injury possibly related to 5-fluorouracil and calcium folinate.

    Internal medicine journal·2007
    Same author

    Ancient polyploidization predating divergence of the cereals, and its consequences for comparative genomics.

    Proceedings of the National Academy of Sciences of the United States of America·2004
    Same author

    Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.

    Alimentary pharmacology & therapeutics·2003
    Same author

    Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis C.

    Internal medicine journal·2001
    Same author

    Interferon-alpha2a/ribaviran versus interferon-alpha2a alone for the retreatment of hepatitis C patients who relapse after a standard course of interferon.

    The New Zealand medical journal·2001
    Same journal

    Reed diffusers: a potential cause of poisoning in young children in New Zealand.

    The New Zealand medical journal·2026
    Same journal

    Stuffy nights: elevated bedroom carbon dioxide concentrations indicate inadequate ventilation in Wellington homes.

    The New Zealand medical journal·2026
    Same journal

    Cautionary tale of how sodium polystyrene sulfonate caused gut necrosis: a case report.

    The New Zealand medical journal·2026
    Same journal

    Emergency lateral canthotomy and cantholysis for acute globe subluxation.

    The New Zealand medical journal·2026
    Same journal

    Liberation of an incarcerated tibialis posterior tendon following a posterior malleolar ankle fracture: a case report.

    The New Zealand medical journal·2026
    Same journal

    Implementing a cultural safety training plan across medical colleges in Aotearoa New Zealand-looking back, and looking forward.

    The New Zealand medical journal·2026
    See all related articles

    Dientamoeba fragilis is an intestinal protozoan that causes gastrointestinal symptoms. Its pathogenic role remains controversial, with varied patient responses to treatment, highlighting diagnostic and therapeutic challenges.

    Area of Science:

    • Medical Parasitology
    • Gastroenterology
    • Infectious Diseases

    Background:

    • Dientamoeba fragilis is an intestinal protozoan.
    • Its role in causing gastrointestinal symptoms is debated.
    • Understanding its pathogenicity is crucial for effective treatment.

    Observation:

    • Three cases of Dientamoeba fragilis infection with gastrointestinal symptoms are presented.
    • Patient 1: Symptoms resolved before parasite eradication.
    • Patient 2: Symptoms persisted despite parasite clearance.
    • Patient 3: Symptom resolution correlated with effective treatment.

    Findings:

    • The pathogenic role of Dientamoeba fragilis is complex and not fully understood.
    • Treatment outcomes vary, with symptom resolution not always linked to parasite eradication.

    Related Experiment Videos

  • Individual patient factors may influence symptom presentation and treatment response.

    • Implications:

    • Further research is needed to clarify the pathogenicity of Dientamoeba fragilis.
    • Diagnostic and treatment strategies may require refinement.
    • This study contributes to understanding the clinical significance of D fragilis infections.